Science 37 is the First and Only FDA-Inspected Direct-to-Patient Clinical Trial Site.
Our Vision
is to accelerate clinical research by expanding patient access resulting in expedited approvals and improved health outcomes for all.
Our Mission
is to develop a team of world-class clinical researchers to expand patient access for clinical trial sponsors by delivering high-quality innovative solutions that enable patients to discover, qualify for, and participate in research, no matter where they are.
Leadership
Experts dedicated to improving patient access in clinical research.
Tyler Van Horn
Chief Executive Officer
Debra Weinstein, MD
Chief Medical Officer
Jeff Richardson
Senior Vice President, Operations
Irena Kowalczyk-Lambridis
Vice President, Head of Quality Assurance & Compliance
Scott Arceri
Vice President, Strategic Solutions
Ashley Covington
Corporate Controller
Ali Wherry
Executive Director, Clinical Operations
Brooke Silva
Director, Nursing Solutions
Awards & Recognitions
Our industry awards reflect our commitment to innovation and excellence.
Science 37 was named “Company of the Year” in the global decentralized clinical trials industry by Frost & Sullivan. Frost & Sullivan's Best Practices Market Leadership Award is bestowed upon companies that exhibit outstanding performance and visionary approaches in their respective industries.
Science 37 was named the winner of “Clinical Efficiency Innovation” in the 8th annual MedTech Breakthrough Awards program in recognition of its Patient Recruitment solution. MedTech Breakthrough is an autonomous market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.
Science 37 was named the winner of the “Market Leadership Award” in the global decentralized clinical trials industry by Frost & Sullivan. Frost & Sullivan's Best Practices Market Leadership Award is bestowed upon companies that exhibit outstanding performance and visionary approaches in their respective industries.
Science 37 was nominated for the prestigious 2023 Prix Galien USA Awards in the category of "Best Digital Health Solution” in recognition of its Direct-to-Patient Site. The Prix Galien Awards, organized by The Galien Foundation, recognize and celebrate groundbreaking innovations in the life sciences industry that significantly advance human health and well-being.
Science 37 was recognized in the 2023 Gartner Hype Cycle for Life Science Clinical Development, which explores areas of innovation that will enable life sciences organizations to respond to industry challenges and provides valuable input necessary to make informed technology investment decisions.
Science 37 was named the winner in the Telehealth Innovation category at the University of California San Francisco (UCSF) Health Hub Digital Health Awards at the 2022 HLTH conference.
Science 37 was recognized by the Everest Group as a Leader in the Decentralized Clinical Trials (DCT) PEAK Matrix Assessment in 2021, 2022, and 2023. The PEAK Matrix provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets. It classifies them into three categories: Leaders, Major Contenders, and Aspirants.
